"A new device developed by UCLA engineers and doctors may eventually help scientists study the development of disease, enable them to capture improved images of the inside of cells and lead to other improvements in medical and biological research."
Arsenal star Mathieu Flamini discusses his passion outside football, a biotechnology company that he runs.
In 2007, physicist Freeman Dyson predicted in an essay called “Our Biotech Future” that “the domestication of biotechnology will dominate our lives during the next fifty years at least as much as the domestication of computers has dominated our lives during the previous fifty years.”
Dyson’s vision sounded surreal. He predicted a future in which children could bioengineer pygmy dinosaurs and adults could power their homes with electricity-generating trees. Over the last eight years, however, the world has slowly moved towards Dyson’s vision.
TechCrunch:
Biotechnology is now taking shape alongside those other big ideas, thanks to reduced costs in robotics, machine learning and some innovative Silicon Valley thinkers. Investors poured more than $3.9 billion into U.S. life sciences in 2014, and there are a growing number of startups in the field.
